Osmium-Tellurium Nanozymes for Pentamodal Combinatorial Cancer Therapy

ACS Appl Mater Interfaces. 2021 Sep 22;13(37):44124-44135. doi: 10.1021/acsami.1c14201. Epub 2021 Sep 8.

Abstract

Although nanoparticles based on Group 8 elements such as Fe and Ru have been developed, not much is known about Os nanoparticles. However, Os-based nanostructures might have potential in various applications including biomedical fields. Therefore, in this study, we synthesized Os-Te nanorods (OsTeNRs) by solvothermal galvanic replacement with Te nanotemplates. We explored the nanozymatic activity of the synthesized OsTeNRs and found that they exhibited superior photothermal conversion and photocatalytic activity. Along with chemotherapy (regorafenib) and immunotherapy, the nanozymatic, photothermal, and photodynamic activities of OsTeNRs were harnessed to develop a pentamodal treatment for hepatocellular carcinoma (HCC); in vitro and in vivo studies demonstrated that the pentamodal therapy could alleviate hypoxia in HCC cells by generating oxygen and reduced unintended drug accumulation in organs. Moreover, bone-marrow toxicity due to regorafenib could be reduced as the drug was released in a sustained manner. Thus, OsTeNRs can be considered as suitable nanotemplates for combinatorial cancer therapy.

Keywords: combinatorial cancer therapy; drug delivery; nanozymes; osmium; photothermal conversion.

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Catalysis
  • Cell Line, Tumor
  • Drug Carriers / chemical synthesis
  • Drug Carriers / chemistry*
  • Drug Carriers / radiation effects
  • Liver Neoplasms / drug therapy*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nanotubes / chemistry*
  • Nanotubes / radiation effects
  • Osmium / chemistry
  • Osmium / radiation effects
  • Phenylurea Compounds / therapeutic use
  • Photochemotherapy
  • Pyridines / therapeutic use
  • Tellurium / chemistry
  • Tellurium / radiation effects
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Phenylurea Compounds
  • Pyridines
  • regorafenib
  • Osmium
  • Tellurium